Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Comparison of initial intraocular pressure response with topical beta-adrenergic antagonists and prostaglandin analogues in African American and white individuals in the Ocular Hypertension Treatment Study.

Mansberger SL, Hughes BA, Gordon MO, Spaner SD, Beiser JA, Cioffi GA, Kass MA; Ocular Hypertension Treatment Study Group.

Arch Ophthalmol. 2007 Apr;125(4):454-9.

PMID:
17420364
2.

Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.

Brandt JD, Beiser JA, Gordon MO, Kass MA; Ocular Hypertension Treatment Study (OHTS) Group.

Am J Ophthalmol. 2004 Nov;138(5):717-22.

PMID:
15531304
3.

The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals.

Higginbotham EJ, Gordon MO, Beiser JA, Drake MV, Bennett GR, Wilson MR, Kass MA; Ocular Hypertension Treatment Study Group.

Arch Ophthalmol. 2004 Jun;122(6):813-20.

PMID:
15197055
4.

Efficacy of latanoprost and timolol maleate in black and white patients.

Kitnarong N, Zhao Y, Netland PA, Kent AR.

Adv Ther. 2004 Jul-Aug;21(4):203-13.

PMID:
15605615
6.

The influence of central corneal thickness on response to topical prostaglandin analogue therapy.

Birt CM, Buys YM, Kiss A, Trope GE; Toronto Area Glaucoma Society.

Can J Ophthalmol. 2012 Feb;47(1):51-4. doi: 10.1016/j.jcjo.2011.12.012.

PMID:
22333852
7.

Meta-analysis of the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs.

Tanna AP, Rademaker AW, Stewart WC, Feldman RM.

Arch Ophthalmol. 2010 Jul;128(7):825-33. doi: 10.1001/archophthalmol.2010.131.

PMID:
20625041
8.

The utility of the monocular trial: data from the ocular hypertension treatment study.

Bhorade AM, Wilson BS, Gordon MO, Palmberg P, Weinreb RN, Miller E, Chang RT, Kass MA; Ocular Hypertension Treatment Study Group.

Ophthalmology. 2010 Nov;117(11):2047-54. doi: 10.1016/j.ophtha.2010.02.020. Epub 2010 Aug 12.

10.

Distribution of intraocular pressure. The Barbados Eye Study.

Leske MC, Connell AM, Wu SY, Hyman L, Schachat AP.

Arch Ophthalmol. 1997 Aug;115(8):1051-7.

PMID:
9258228
11.
12.

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO.

Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30.

PMID:
12049574
13.

Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.

Shimmyo M.

Am J Ophthalmol. 2005 Jun;139(6):1148; author reply 1148-9. No abstract available.

PMID:
15953471
14.

Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study.

Piltz J, Gross R, Shin DH, Beiser JA, Dorr DA, Kass MA, Gordon MO.

Am J Ophthalmol. 2000 Oct;130(4):441-53.

PMID:
11024416
15.

A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.

Denis P, Lafuma A, Khoshnood B, Mimaud V, Berdeaux G.

Curr Med Res Opin. 2007 Mar;23(3):601-8. Review.

PMID:
17355741
16.

Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.

Higginbotham EJ, Olander KW, Kim EE, Grunden JW, Kwok KK, Tressler CS; United States Fixed-Combination Study Group.

Arch Ophthalmol. 2010 Feb;128(2):165-72. doi: 10.1001/archophthalmol.2009.384.

PMID:
20142538
18.

Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol.

Rácz P, Ruzsonyi MR, Nagy ZT, Gaygi Z, Bito LZ.

Arch Ophthalmol. 1996 Mar;114(3):268-73.

PMID:
8600885
19.

Prostaglandin efficacy and safety study undertaken by race (the PRESSURE study).

Birt CM, Buys YM, Ahmed II, Trope GE; Toronto Area Glaucoma Society.

J Glaucoma. 2010 Sep;19(7):460-7. doi: 10.1097/IJG.0b013e3181c4aeac.

PMID:
20051890

Supplemental Content

Support Center